Diversified Healthcare Trust DHC
- Market cap
- $2.0B
- P/E
- 0.0×
Follow DHC
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.53 | 18.26 | 11.13 | 7.05 | 2.00 | 2.35 | 0.61 | 0.64 | 2.13 | 2.00 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 23.85 | 22.52 | 19.39 | 14.31 | 8.93 | 5.58 | 3.45 | 3.96 | 4.24 | 5.16 |
High Price
|
|||
| 450 | 550 | 600 | 600 | 600 | — | — | — | — | — |
Employees
|
|||
| 2 | 2 | 2 | 2 | 3 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 1,058 | 1,075 | 1,117 | 1,040 | 1,632 | 1,383 | 1,284 | 1,410 | 1,495 | 1,538 |
Revenue
|
|||
| 62.21% | 61.53% | 59.58% | 52.98% | 24.24% | 21.07% | 13.59% | 16.75% | 17.31% | 18.11% |
Gross Margin
|
|||
| 142 | 152 | 292 | (83) | (133) | 181 | (21) | (273) | (371) | (321) |
EBT
|
|||
| 13.38% | 14.11% | 26.17% | (7.96%) | (8.15%) | 13.11% | (1.65%) | (19.33%) | (24.83%) | (20.87%) |
EBT Margin
|
|||
| 141 | 152 | 292 | (83) | (134) | 180 | (16) | (294) | (370) | (286) |
Net Income
|
|||
| 289 | 277 | 287 | 288 | 271 | 277 | 248 | 296 | 389 | 340 |
Depreciation
|
|||
| 4.46 | 4.53 | 4.70 | 4.38 | 6.86 | 5.81 | 5.39 | 5.90 | 6.24 | 6.40 |
Revenue/Sh
|
|||
| 0.60 | 0.62 | 1.21 | (0.37) | (0.59) | 0.73 | (0.07) | (1.23) | (1.55) | (1.19) |
Earnings/Sh
|
|||
| 1.79 | 1.77 | 1.65 | 1.12 | 0.67 | (0.27) | (0.17) | 0.04 | 0.47 | (0.08) |
Cash Flow/Sh
|
|||
| (1.23) | (0.93) | 0.42 | (0.08) | (0.17) | (0.52) | 1.11 | (0.91) | (0.70) | 1.84 |
Capex/Sh
|
|||
| 0.55 | 0.83 | 2.07 | 1.04 | 0.50 | (0.79) | 0.94 | (0.86) | (0.23) | 1.76 |
Free CF/Sh
|
|||
| 13.48 | 13.80 | 13.39 | 12.11 | 11.02 | 11.19 | 11.07 | 9.78 | 8.18 | 6.93 |
Book Value/Sh
|
|||
| 237 | 237 | 238 | 238 | 238 | 238 | 238 | 239 | 240 | 240 |
Shares
|
|||
| 31.77 | 31.03 | 9.77 | 0.00 | 0.00 | 4.18 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| 4.28 | 4.25 | 2.49 | 1.93 | 0.60 | 0.53 | 0.12 | 0.61 | 0.37 | 0.76 |
PS Ratio
|
|||
| 1.41 | 1.39 | 0.88 | 0.70 | 0.37 | 0.28 | 0.06 | 0.37 | 0.28 | 0.70 |
PB Ratio
|
|||
| 7.75 | 7.63 | 5.69 | 5.68 | 2.87 | 2.45 | 1.96 | 2.75 | 2.52 | 2.53 |
EV/Sales
|
|||
| 62.32 | 41.42 | 12.93 | 23.92 | 39.81 | (18.09) | 11.21 | (18.81) | (68.01) | 9.21 |
EV/FCF
|
|||
| 424 | 419 | 393 | 266 | 159 | (63) | (40) | 10 | 112 | (20) |
Op' Cash Flow
|
|||
| (293) | (221) | 99 | (19) | (41) | (124) | 265 | (217) | (168) | 442 |
Capex
|
|||
| 132 | 198 | 492 | 247 | 118 | (188) | 224 | (206) | (55) | 423 |
FCF
|
|||
| 13 | (19) | 8 | 21 | 43 | 179 | (38) | 223 | 122 | 72 |
Working Cap'
|
|||
| 3,735 | 3,675 | 4,094 | 3,956 | 3,802 | 3,677 | 3,048 | 2,817 | 2,911 | 2,401 |
Total Debt
|
|||
| 3,700 | 3,627 | 4,024 | 3,903 | 3,711 | 2,660 | 2,360 | 2,570 | 2,761 | 2,279 |
Net Debt
|
|||
| 3,199 | 3,277 | 3,180 | 2,877 | 2,619 | 2,662 | 2,639 | 2,337 | 1,959 | 1,666 |
Sh' Equity
|
|||
| 1.96% | 2.03% | 3.97% | (1.28%) | (2.12%) | 2.66% | (0.25%) | (5.13%) | (7.00%) | (6.02%) |
ROA
|
|||
| 2.75% | 2.49% | 1.97% | 0.89% | (0.13%) | (0.37%) | (1.17%) | (1.32%) | (1.67%) | (3.25%) |
ROIC
|
|||
| 4.31% | 4.56% | 8.89% | (2.91%) | (5.07%) | 6.61% | (0.60%) | (11.80%) | (17.24%) | (15.78%) |
ROE
|
|||
Diversified Healthcare Trust peers in Reit Healthcare Facilities
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| MPT Medical Properties Trust, Inc. | $2.1B | 0.0× | Compare |
| LTC LTC Properties, Inc. | $2.3B | 15.7× | Compare |
| NHI National Health Investors, Inc. | $3.3B | 19.3× | Compare |
| SBRA Sabra Healthcare REIT, Inc. | $5.1B | 76.3× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| STRW Strawberry Fields REIT, Inc. | $742.6M | 20.6× | Compare |
| HR Healthcare Realty Trust Incorporated | $6.1B | 0.0× | Compare |
| UHT Universal Health Realty Income Trust | $537.6M | 27.8× | Compare |
| XRN Chiron Real Estate Inc. | $518.6M | 9.6× | Compare |
Diversified Healthcare Trust (DHC) key facts
- Diversified Healthcare Trust (DHC) is a Reit Healthcare Facilities company in the Real Estate sector, listed on Nasdaq.
- Diversified Healthcare Trust’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.84% from fiscal 2024.
- Diversified Healthcare Trust reported a net loss of $285.9 million, or a loss of $1.19 per share, for fiscal 2025.
- As of September 25, 2026, DHC traded at $8.13, a market capitalization of $2.0 billion.
- Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 1.3× sales.
- Diversified Healthcare Trust pays an annual dividend of $0.04 per share, a yield of 1.52%, with a payout ratio of 2.34%.
- Return on equity was −15.8% and debt-to-equity 1.52.
Diversified Healthcare Trust (DHC) Latest News
4 Aug
Diversified Healthcare Trust reported 37% SHOP NOI growth in Q2 2026 earnings call. 37% SHOP NOI surge signals major operational gains that can shift DHC financial trajectory and investor views.
Diversified Healthcare Trust Q2 earnings call covered financial performance, operational updates, occupancy trends, and management outlook. Quarterly earnings details and forward guidance can moderately shift investor views on near-term financial trajectory.
Diversified Healthcare Trust held its Q2 2026 earnings call to review financial results and operations. Quarterly earnings updates provide performance data that can shift near-term investor sentiment and stock valuation.
3 Aug
Diversified Healthcare Trust posted Q2 FFO above analyst estimates. Beating Q2 FFO estimates indicates better-than-expected operational results likely to lift near-term investor sentiment.
Diversified Healthcare Trust released second quarter 2026 financial results. Quarterly earnings reports supply core financial metrics that shape near-term valuation and sentiment.
22 Jun
RBC Capital forecasts healthy earnings growth ahead for Diversified Healthcare Trust (DHC). Analyst earnings growth forecast may influence near-term investor sentiment for DHC without indicating major operational shifts.
1 Jun
Diversified Healthcare Trust raised 2026 guidance due to faster cost savings from recent operator transitions. Raised 2026 guidance from accelerating cost savings directly improves earnings outlook and investor sentiment.
12 May
Diversified Healthcare Trust (DHC) stock surged 176% recently, raising questions if it's too late to invest. 176% stock surge signals major shift in market performance and investor sentiment for DHC.
8 May
The RMR Group released Q2 earnings call highlights, detailing performance metrics and updates relevant to its managed REIT, Diversified Healthcare Trust (DHC). RMR Group's Q2 earnings highlights provide insights into DHC's operational health and financials, with moderate influence on market sentiment.
5 May
Diversified Healthcare Trust released Q1 2026 earnings call summary highlighting quarterly financial results, operational updates, and forward guidance. Q1 2026 earnings call summary discloses key financial metrics and outlook that significantly influence stock performance and investor sentiment.
Diversified Healthcare Trust released Q1 earnings call highlights covering financial results, occupancy rates, rental income, debt management, and outlook for healthcare properties portfolio. Q1 earnings highlights reveal financial performance and operational updates with moderate influence on investor sentiment and stock trajectory.
4 May
Diversified Healthcare Trust (DHC) beat first-quarter FFO estimates, reporting stronger-than-expected results that boosted shares. Beating Q1 FFO estimates indicates solid financial performance with moderate positive influence on investor sentiment and stock trajectory.
Diversified Healthcare Trust announced first quarter 2026 financial results, highlighting key performance metrics for the period. Quarterly earnings announcements affect financial performance and market sentiment but are routine without transformative details.
9 Mar
Diversified Healthcare Trust (DHC) narrowed losses while emphasizing net operating income (NOI), potentially shifting its investment narrative toward improved financial stability and operational focus. Narrowing losses and NOI focus signal moderate improvements in financial performance and investor sentiment without transformative changes.
24 Feb
Diversified Healthcare Trust released Q4 2025 earnings call summary detailing financial results, operational updates, and future outlook for the healthcare REIT. Q4 earnings call summaries disclose key financial metrics and guidance that significantly sway investor sentiment and stock trajectory.
Diversified Healthcare Trust (DHC) reported strong revenue growth in Q4 2025 earnings call highlights. Strong Q4 2025 revenue growth highlights significant positive financial momentum for future performance.
Diversified Healthcare Trust released Q4 earnings call highlights, detailing financial results, operational updates, and forward-looking guidance. Q4 earnings highlights disclose key financial metrics, occupancy rates, and strategic outlook directly influencing DHC's valuation and investor sentiment.
23 Feb
Diversified Healthcare Trust released Q4 earnings snapshot, reporting key financial metrics for the quarter. Q4 earnings snapshots reveal critical financial results that drive significant shifts in investor sentiment and DHC stock performance.
Diversified Healthcare Trust (DHC) missed Q4 FFO and revenue estimates. Missing Q4 FFO and revenue estimates signals weaker financial performance, impacting investor sentiment and near-term stock trajectory.
Diversified Healthcare Trust announced fourth quarter 2025 results, reporting key financial metrics including revenue, net income, FFO, and portfolio occupancy. Quarterly earnings announcements provide visibility into financial health and operational performance, influencing short-to-medium term market sentiment.
19 Feb
RLJ stock has fallen 8% over the past year, but a $71 million position signals strong conviction in Diversified Healthcare Trust (DHC). $71 million position indicates significant investor conviction boosting DHC's market sentiment and trajectory.
28 Jan
Diversified Healthcare Trust (DHC) reported its 2025 incentive fee results following the initiation of coverage by Ladenburg Thalmann. The results indicate a focus on performance metrics that could influence investor sentiment and future financial strategies. The announcement highlights DHC's commitment to aligning management incentives with shareholder interests, potentially impacting its market positioning. The incentive fee results may moderately influence DHC's financial performance and investor perception.
24 Jan
Diversified Healthcare Trust (DHC) has experienced notable share price momentum recently, prompting a reevaluation of its valuation. Analysts are assessing the implications of this price movement on DHC's future performance and market positioning. Factors influencing this momentum include market trends, investor sentiment, and potential strategic decisions by the company. The analysis aims to provide insights into whether the current share price reflects the company's underlying value and future growth prospects. Recent share price momentum may moderately influence DHC's financial performance and market perception.
23 Jan
Diversified Healthcare Trust (DHC) has been identified as a strong sell stock for January 23rd due to ongoing financial struggles and market challenges. Analysts express concerns over its ability to recover, citing declining revenues and potential risks associated with its operational strategies. Investors are advised to reconsider their positions in light of these developments, as the company's future performance appears uncertain. Significant financial struggles and market challenges are likely to impact DHC's future performance and investor sentiment.
20 Jan
Diversified Healthcare Trust (DHC) has announced its dividend allocation for 2025, detailing the distribution plan for shareholders. The allocation reflects the company's ongoing commitment to providing returns to investors while navigating the current market conditions. DHC aims to maintain its financial stability and support its operational strategies through this dividend decision. The dividend allocation indicates a commitment to shareholder returns, which may positively influence market sentiment but does not fundamentally alter the company's trajectory.
14 Jan
The RMR Group announced that it earned $23.6 million in incentive business management fees for Diversified Healthcare Trust (DHC) in the calendar year 2025. This figure reflects the company's performance and management effectiveness in the healthcare real estate sector, contributing to its overall financial results. Earnings from incentive fees indicate a moderately noticeable influence on DHC's financial performance and market sentiment.
5 Jan
Diversified Healthcare Trust (DHC) provided a business update highlighting its ongoing efforts to enhance operational efficiency and financial stability. The company is focusing on optimizing its portfolio and addressing challenges in the healthcare real estate sector. DHC is also exploring strategic partnerships and potential asset sales to improve liquidity and strengthen its balance sheet. The update reflects DHC's commitment to navigating current market conditions while positioning itself for future growth. The update indicates a moderate influence on DHC's operational strategy and financial performance amid ongoing market challenges.
19 Dec
Diversified Healthcare Trust (DHC) is highlighted as an undervalued small-cap stock with notable insider activity, suggesting potential growth opportunities. The article emphasizes the importance of monitoring insider transactions as a signal for future performance, particularly in December 2025. Investors are encouraged to consider DHC among other small-cap stocks showing similar trends. Insider activity may influence investor sentiment and financial performance, but its overall effect is expected to be limited.
11 Nov
Diversified Healthcare Trust (DHC) is highlighted as a strong momentum stock due to its recent performance and strategic positioning in the healthcare real estate sector. The company has shown resilience and growth potential, attracting investor interest. Analysts suggest that DHC's fundamentals, including its financial health and market trends, support a positive outlook, making it a compelling buy for investors looking for momentum stocks in the healthcare space. DHC's strategic positioning and recent performance indicate significant potential for future growth and investor interest.
7 Nov
Diversified Healthcare Trust (DHC) reported mixed results for Q3 2025, showing a decline in revenue and an increase in losses. The company faced challenges in its operational performance, leading to concerns about its future financial stability. Analysts are reassessing DHC's valuation in light of these results, which may impact investor sentiment and market positioning. Mixed Q3 results and growing losses indicate a moderately noticeable influence on financial performance and market sentiment.